[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355174-105":59,"doc-detail-355174-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","beta-hydroxybutyrate-a-primary-metabolite-of-ketogenic-diets-and-its-dual-role-in-modulating-colorectal-cancer-from-molecular-mechanisms-to-therapeutic-insights","β-Hydroxybutyrate, a primary metabolite of ketogenic diets and its dual role in modulating colorectal cancer - from molecular mechanisms to therapeutic insights","","Colorectal cancer (CRC) is a genetically diverse malignancy with metabolic flexibility that allows tumor cells to switch between energy sources. Beta-hydroxybutyrate (BHB), elevated during ketogenic diets, is widely studied for therapeutic potential, yet emerging evidence suggests it can also promote CRC progression by serving as an alternative fuel. This review analyzes how CRC cells use BHB to enhance metabolic plasticity, resist apoptosis, and alter chemotherapy and immunotherapy responses, and how BHB shapes the tumor microenvironment and immune activity. The synthesis argues for personalized therapeutic strategies based on genetic and metabolic tumor features.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/beta-hydroxybutyrate-a-primary-metabolite-of-ketogenic-diets-and-its-dual-role-in-modulating-colorectal-cancer-from-molecular-mechanisms-to-therapeutic-insights/355174/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/beta-hydroxybutyrate-a-primary-metabolite-of-ketogenic-diets-and-its-dual-role-in-modulating-colorectal-cancer-from-molecular-mechanisms-to-therapeutic-insights/355174.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is beta-hydroxybutyrate (BHB) considered a dual factor in colorectal cancer?","Question",{"text":112,"@type":113},"BHB is elevated during ketogenic diets and has potential benefits, but recent evidence indicates it can also facilitate CRC advancement by acting as an alternative energy source for cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the review describe mechanisms linking BHB to colorectal cancer survival and treatment response?",{"text":117,"@type":113},"The review focuses on increased metabolic plasticity, resistance to apoptosis, and modified responses to chemotherapy and immunotherapy, alongside effects on how CRC cells metabolize BHB.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does the tumor microenvironment (TME) play in BHB’s effects?",{"text":121,"@type":113},"The review emphasizes that BHB can influence immune responses and tumor progression through interactions with the TME, affecting how the tumor and host immunity behave.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355174,1790814766,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Clinical and Experimental Medicine (2026) 26:168  \n[https://doi.org/10.1007/s10238-026-02085-8](https://doi.org/10.1007/s10238-026-02085-8)  \nREVIEW  \nβ-Hydroxybutyrate, a primary metabolite of ketogenic diets and its dual role in modulating colorectal cancer: from molecular mechanisms to therapeutic insights  \nParisa Rashidi1 · Zahra Bagheri2 · Zahra Khodayar3 · Saba Tarkashvand4,5,6 · Negin Elahirad7 · Reihaneh Akhoondi5,6 · Sepehr Hoseinzadeh Moghaddam8 · Masoud Sanati9 · Roya Haghighatjou10 · Reza Yekani11 · Mahtab Mehboodi12 · Armita Banimahdidehkordi13 · Saman Rabiei2 · Houra Dinvari14 · Mohammad Hasan Maleki15  \nReceived: 1 December 2025 / Accepted: 2 February 2026 © The Author(s) 2026  \nAbstract  \nColorectal cancer (CRC) is a genetically varied malignancy noted for its metabolic flexibility, which enables cancer cells to adapt to different energy sources. Beta-hydroxybutyrate (BHB), a significant ketone body that is elevated during ketogenic diets, has attracted considerable attention for its potential therapeutic benefits. However, recent evidence indicates that BHB may paradoxically facilitate the advancement of CRC by acting as an alternative energy source, especially in cancer cells with mutations in critical genes such as APC, KRAS, and TP53 . This review investigates the mechanisms through which CRC cells utilize BHB for their survival, focusing on enhanced metabolic plasticity, resistance to apoptosis, and modified responses to chemotherapy and immunotherapy. It also explores the interaction between BHB and the tumor microenvironment (TME), emphasizing how BHB can influence immune responses and tumor progression. Given  \nParisa Rashidi and Zahra Bagheri have equally contributed to this study as first authors.  \n􀀍 Saman Rabiei[r_saman22@hotmail.com](r_saman22@hotmail.com)  \n􀀍 Houra Dinvari [houra.dn@gmail.com](houra.dn@gmail.com)  \n􀀍 Mohammad Hasan Maleki[mhmlkteh@gmail.com](mhmlkteh@gmail.com)  \n1 Cellular and Molecular research center, Ahvaz Jundishapur University of medical Sciences, Ahvaz, Iran  \n2 Clinical Research Development Unit, Valiasr Hospital, Fasa University of Medical Sciences, Fasa, Fars, Iran  \n3 Department of Biotechnology, Faculty of Converging Sciences and Technologies, Science and Research Branch, Islamic Azad University, Tehran, Iran  \n4 Sina Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran  \n5 Universal Scientific Education and Research Network (USERN), Tehran University of Medical Science, Tehran, Iran  \n6 Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran  \n7 Department of Parasitology, Pasteur Institute of Iran, Tehran, Iran  \n8 School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran  \n9 Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran  \n10 Research Center for Development of Nursing and Midwifery Sciences, Najafabad Branch, Islamic Azad University, Najafabad, Iran  \n11 Department of Biochemistry and Biophysics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran  \n12 Department of Medical Microbiology (Bacteriology & Virology), Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran  \n13 Department of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran  \n14 Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran  \n15 Department of Clinical Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran  \n1 3  \nthe complexity of BHB’s role in CRC, the review underscores the necessity for personalized approaches that consider the tumor’s genetic and metabolic characteristics. Understanding the dual role of BHB in CRC is essential for devising more effective therapeutic strategies that can either harness or counteract its effects, thereby guiding the application of ketogenic diets and other metabolic interventions i","cbCaiohtc2P6O2zQ","https://ap.wps.com/l/cbCaiohtc2P6O2zQ","pdf",1948010,15,"English","# Abstract\n# Introduction\n# Beta-hydroxybutyrate: metabolism and function\n## Synthesis of beta-hydroxybutyrate","[{\"question\":\"Why is beta-hydroxybutyrate (BHB) considered a dual factor in colorectal cancer?\",\"answer\":\"BHB is elevated during ketogenic diets and has potential benefits, but recent evidence indicates it can also facilitate CRC advancement by acting as an alternative energy source for cancer cells.\"},{\"question\":\"How does the review describe mechanisms linking BHB to colorectal cancer survival and treatment response?\",\"answer\":\"The review focuses on increased metabolic plasticity, resistance to apoptosis, and modified responses to chemotherapy and immunotherapy, alongside effects on how CRC cells metabolize BHB.\"},{\"question\":\"What role does the tumor microenvironment (TME) play in BHB’s effects?\",\"answer\":\"The review emphasizes that BHB can influence immune responses and tumor progression through interactions with the TME, affecting how the tumor and host immunity behave.\"}]","β-Hydroxybutyrate, a primary metabolite of ketogenic diets and its dual role in modulating colorectal cancer - from molecular mechanisms to therapeutic insights | PDF",1790116510,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/659226b63f87f5b24be77fed61113b4f.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a0ad4d945df686ef4558247ac9e65ab.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81b510e58640ca0b2b76addca65c7f68.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6066e137d2e086853341c318d24a430a.webp",980,1301]